Patents by Inventor Maja Sommerfelt Grønvold

Maja Sommerfelt Grønvold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent
    Patent number: 10449245
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods for treatment of HIV infection and prevention of AIDS.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: October 22, 2019
    Assignee: Bionor Immuno AS
    Inventors: Anker Lundemose, Mats Ökvist, Arnt Ove Hovden, Maja Sommerfelt Grønvold
  • Stabilized HIV-1 peptide constructs comprising the gp120 C5 domain and gp41 hydrophilic domain
    Patent number: 10251949
    Abstract: Disclosed is a method for treatment of HIV related diseases comprising targeting complexes between on the one hand the C5 domain of gp120 and on the other hand gp41 or the C2 domain of gp120. The complexes may be stabilised by administering compounds, such as antibodies, capable of directly interacting with and stabilising the complex, or by immunizing with C5 and gp41/C2 derived material so as to induce antibodies that bind to and stabilise the complex.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: April 9, 2019
    Assignee: BIONOR IMMUNO AS
    Inventors: Maja Sommerfelt Grønvold, Angus Dalgleish, Einar Tønnes Lange, Jens Olof Holmberg, Per Bengtsson, Birger Sørensen
  • Method for the vaccination against HIV
    Patent number: 10143737
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods to select HIV infected patients with improved responses to HIV-specific vaccine peptides.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: December 4, 2018
    Assignee: BIONOR PHARMA ASA
    Inventors: Anker Lundemose, Mats Ökvist, Arnt Ove Hovden, Maja Sommerfelt Grønvold
  • Dimeric scaffold peptides comprising HIV-1 GP120 and GP41 epitopes
    Patent number: 10124059
    Abstract: The present invention relates to novel peptides and methods for inducing an immune response in a subject against an antigen and for treatment, diagnosis and prognosis of infections or autoimmune diseases including infections with HCV, HIV, CMV and Flu. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: November 13, 2018
    Assignee: BIONOR IMMUNO AS
    Inventors: Einar Tønnes Lange, Maja Sommerfelt Grønvold, Birger Sørensen, Karolina Lawitz
  • DOSAGE REGIMEN FOR HIV VACCINE
    Publication number: 20180140694
    Abstract: The present invention relates to a novel dosage regimen in the treatment of HIV infections and AIDS. In particular, the present invention relates to a specific novel use of formulations of HIV-specific protein therapeutics, such as anti-HIV-1 specific antibodies and/or HIV-specific vaccine peptides, administered in a dosing regimen together with a latent viral reservoir purging agent. The formulations may further be administered with one or more other therapeutic agents, such as in combination with at least one immunomodulatory compound and/or other reservoir purging agents, such as histone deacetylase (HDAC) inhibitors.
    Type: Application
    Filed: May 4, 2016
    Publication date: May 24, 2018
    Applicant: BIONOR IMMUNO AS
    Inventors: Anker Lundemose, Mats Ökvist, Arnt Ove Hovden, Maja Sommerfelt Grønvold
  • METHOD FOR REDUCING AND/OR DELAYING PATHOLOGICAL EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS I (HIV) OR FOR REDUCING THE RISK OF DEVELOPING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
    Publication number: 20170165321
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods for treatment of HIV infection and prevention of AIDS.
    Type: Application
    Filed: July 9, 2015
    Publication date: June 15, 2017
    Applicant: Bionor Immuno AS
    Inventors: Anker Lundemose, Mats Ökvist, Arnt Ove Hovden, Maja Sommerfelt Grønvold
  • PEPTIDE SCAFFOLD DESIGN
    Publication number: 20170112917
    Abstract: The present invention relates to novel peptides and methods for treatment, diagnosis and prognosis of virus infections including infections with HCV, HIV, CMV and Influenza. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 27, 2017
    Applicant: Bionor Immuno AS
    Inventors: Einar Tønnes Lange, Maja Sommerfelt Grønvold, Jens Olof Holmberg, Birger Sørensen
  • DOSAGE REGIMEN FOR HIV VACCINE
    Publication number: 20170043009
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods for treatment of HIV infection and prevention of AIDS.
    Type: Application
    Filed: January 27, 2015
    Publication date: February 16, 2017
    Applicant: Bionor Immuno AS
    Inventors: Anker LUNDEMOSE, Mats ÖKVIST, Arnt Ove HOVDEN, Maja Sommerfelt GRØNVOLD
  • Peptide scaffold design
    Patent number: 9550811
    Abstract: The present invention relates to novel peptides and methods for treatment, diagnosis and prognosis of virus infections including infections with HCV, HIV, CMV and Influenza. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: January 24, 2017
    Assignee: BIONOR IMMUNO AS
    Inventors: Einar Tønnes Lange, Maja Sommerfelt Grønvold, Jens Olof Holmberg, Birger Sørensen
  • METHOD FOR THE VACCINATION AGAINST HIV
    Publication number: 20170000876
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods to select HIV infected patients with improved responses to HIV-specific vaccine peptides.
    Type: Application
    Filed: January 27, 2015
    Publication date: January 5, 2017
    Applicant: Bionor Immuno AS
    Inventors: Anker LUNDEMOSE, Mats ÖKVIST, Arnt Ove HOVDEN, Maja Sommerfelt GRØNVOLD
  • DIMERIC SCAFFOLD PEPTIDES COMPRISING HIV-1 GP120 AND GP41 EPITOPES
    Publication number: 20160375129
    Abstract: The present invention relates to novel peptides and methods for inducing an immune response in a subject against an antigen and for treatment, diagnosis and prognosis of infections or autoimmune diseases including infections with HCV, HIV, CMV and Flu. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Application
    Filed: September 14, 2016
    Publication date: December 29, 2016
    Applicant: BIONOR IMMUNO AS
    Inventors: Einar Tønnes Lange, Maja Sommerfelt Grønvold, Birger Sørensen, Karolina Lawitz
  • Novel Therapeutic and Diagnostic Means
    Publication number: 20160144019
    Abstract: Disclosed is a method for treatment of HIV related diseases comprising targeting complexes between on the one hand the C5 domain of gp120 and on the other hand gp41 or the C2 domain of gp120. The complexes may be stabilised by administering compounds, such as antibodies, capable of directly interacting with and stabilising the complex, or by immunizing with C5 and gp41/C2 derived material so as to induce antibodies that bind to and stabilise the complex.
    Type: Application
    Filed: November 25, 2015
    Publication date: May 26, 2016
    Applicant: Bionor Immuno AS
    Inventors: Maja Sommerfelt GRØNVOLD, Angus DALGLEISH, Einar Tønnes LANGE, Jens Olof HOLMBERG, Per BENGTSSON, Birger SØRENSEN
  • Peptide constructs derived from the GP120 C5 domain and GP41 transmembrane domain
    Patent number: 9200065
    Abstract: Disclosed is a method for treatment of HIV related diseases comprising targeting complexes between on the one hand the C5 domain of gp120 and on the other hand gp41 or the C2 domain of gp120. The complexes may be stabilised by administering compounds, such as antibodies, capable of directly interacting with and stabilising the complex, or by immunizing with C5 and gp41/C2 derived material so as to induce antibodies that bind to and stabilise the complex.
    Type: Grant
    Filed: July 3, 2010
    Date of Patent: December 1, 2015
    Assignee: Bionor Immuno AS
    Inventors: Maja Sommerfelt Grønvold, Angus Dalgleish, Einar Tønnes Lange, Jens Olof Holmberg, Per Bengtsson, Birger Sørensen
  • MONOMERIC AND MULTIMERIC IMMUNOGENIC PEPTIDES
    Publication number: 20140044746
    Abstract: The present invention relates to novel peptides and methods for inducing an immune response in a subject against an antigen and for treatment, diagnosis and prognosis of infections or autoimmune diseases including infections with HCV, HIV, CMV and Flu. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Application
    Filed: January 6, 2012
    Publication date: February 13, 2014
    Applicant: BIONOR IMMUNO AS
    Inventors: Einar Tønnes Lange, Maja Sommerfelt Grønvold, Birger Sørensen, Karolina Lawitz
  • PEPTIDE SCAFFOLD DESIGN
    Publication number: 20130337002
    Abstract: The present invention relates to novel peptides and methods for treatment, diagnosis and prognosis of virus infections including infections with HCV, HIV, CMV and Influenza. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Application
    Filed: December 2, 2011
    Publication date: December 19, 2013
    Applicant: BIONOR IMMUNO AS
    Inventors: Einar Tønnes Lange, Maja Sommerfelt Grønvold, Jens Olof Holmberg, Birger Sørensen
  • Novel Therapeutic and Diagnostic Means
    Publication number: 20120263720
    Abstract: Disclosed is a method for treatment of HIV related diseases comprising targeting complexes between on the one hand the C5 domain of gp120 and on the other hand gp41 or the C2 domain of gp120. The complexes may be stabilised by administering compounds, such as antibodies, capable of directly interacting with and stabilising the complex, or by immunizing with C5 and gp41/C2 derived material so as to induce antibodies that bind to and stabilise the complex.
    Type: Application
    Filed: July 3, 2010
    Publication date: October 18, 2012
    Applicant: Bionor Immuno AS
    Inventors: Maja Sommerfelt Grønvold, Angus Dalgleish, Einar Tønnes Lange, Jens Olof Holmberg, Per Bengtsson, Birger Sørensen